The risk of thyroid cancer, specifically medullary thyroid carcinoma, has been noted, and as such, Wegovy product manufacturers addressed safety warning against use in individuals with a personal or family history of multiple endocrine neoplasia syndrome type 2
GLP-1 Agonist Weight Loss Drugs Trulicity (dulaglutide), Byetta (exenatide), Bydureon BCise (exenatide extended release), Victoza (liraglutide), Adlyxin (lixisenatide), Ozempic, Rybelsus (semaglutide subcutaneous, tablet), Mounjaro (tirzepatide)
10.1054/mehy.1998.0780 Shungu, D.C., N
This can make weight loss feel more achievable than it has for years
Experience a transformative journey towards a healthier you with our medical weight loss solutions
Do not attempt to adjust your dose or stop the medication without medical advice